Leonard W Rozamus

USPTO Granted Patents = 23 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 267(Granted Patents)

Location History:

Bedford, MA (US) (2001 - 2015)
Andover, MA (US) (2016 - 2022)

Company Filing History:

15 out of 69

Ariad Pharmaceuticals, Inc.

patents

6 out of 13

Ariad Gene Therapeutics, Inc.

patents

1 out of 1,179

Takeda Pharmaceutical Company Limited

patents

4. 1 out of 1

Araid Gene Therapeutics, Inc.

patent

Years Active: 2001-2022

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11427605 - Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine (2022-08-30),

2. 11384086 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2022-07-12),

3. 11279705 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2022-03-22),

4. 11192897 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),

5. 11192896 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),

6. 11192895 - Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2021-12-07),

7. 10934317 - Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine (2021-03-02),

8. 10662197 - Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2020-05-26),

9. 10385078 - Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine (2019-08-20),

10. 10125136 - Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2018-11-13),

11. 9493470 - Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt (2016-11-15),

12. 9024014 - Phosphorus-containing compounds and uses thereof (2015-05-05),

13. 8058426 - Phosphorus-containing compounds and uses thereof (2011-11-15),

14. 7709020 - Implantable device comprising phosphorus-containing macrolides (2010-05-04),

15. 7432277 - Phosphorus-containing macrocycles (2008-10-07),

Title: Leonard W Rozamus - Pioneering Inventor from Andover

Introduction: Leonard W Rozamus is a distinguished inventor hailing from Andover, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Leonard W Rozamus holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his illustrious career, Leonard W Rozamus has been recognized for his exceptional work in developing cutting-edge solutions that have had a significant impact on industries worldwide.

Collaborations: Leonard W Rozamus has collaborated with leading companies, research institutions, and universities to further his inventions and bring them to fruition, solidifying his reputation as a visionary inventor.

Conclusion: Leonard W Rozamus continues to inspire aspiring inventors with his remarkable achievements and unwavering dedication to pushing the boundaries of innovation.

This text is generated by artificial intelligence and may not be accurate.